Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 3 boards, counting each seat separately. Longest: BridgeBio Pharma Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
BridgeBio Pharma Inc. June 20, 202582.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 22, 2026 | BridgeBio Pharma Inc. | Grant or award | +3,990 | — | — |
| May 20, 2026 | Equitable Holdings Inc. | Grant or award | +4,400 | $42.05 | $185,020 |
| Jun 20, 2025 | BridgeBio Pharma Inc. | Grant or award | +6,589 | — | — |
| May 21, 2025 | Equitable Holdings Inc. | Grant or award | +3,393 | — | — |
| Feb 3, 2025 | The PNC Financial Services Group Inc. | Open-market purchase | +100 | $198.13 | $19,813 |
Questions about Douglas A. Dachille
What boards is Douglas A. Dachille on?
Douglas A. Dachille sits on the boards of BridgeBio Pharma Inc., Equitable Holdings Inc. and The PNC Financial Services Group Inc.
How long has Douglas A. Dachille served on boards?
Our records show at least 7 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.